Pathology primer: Common liver biopsy findings in patients who have recently undergone liver transplant or resection
Oyedele A. Adeyi – 30 August 2017
Pathology primer: Common liver biopsy findings in patients who have recently undergone liver transplant or resection
Oyedele A. Adeyi – 30 August 2017
Altered mental status after liver transplant
Helen S. Te – 30 August 2017
What's new in our understanding of the pathogenesis of hepatic encephalopathy?
Christopher F. Rose – 30 August 2017
Glucagon‐like peptide‐1 analogues in nonalcoholic steatohepatitis: From bench to bedside
Matthew J. Armstrong, on behalf of BASL and the Dame Sheila Sherlock Award 2016 – 30 August 2017
Pathology and differential diagnosis of hepatic venous outflow impairment
Raouf E. Nakhleh – 30 August 2017
Donation after cardiac death in the hepatocellular carcinoma patient: Same indication?
Charles C. Vining, Brett L. Ecker, Peter L. Abt, Kim M. Olthoff – 28 August 2017
Controversies in liver transplantation: A new series for the journal
James F. Trotter – 28 August 2017
Reply
Sezai Yilmaz – 28 August 2017
High‐mobility‐group protein 2 regulated by microRNA‐127 and small heterodimer partner modulates pluripotency of mouse embryonic stem cells and liver tumor initiating cells
Yulan Zhao, Zhihong Yang, Jianguo Wu, Raymond Wu, Santosh K. Keshipeddy, Dennis Wright, Li Wang – 28 August 2017 – High‐mobility‐group protein 2 (HMGB2) expression is up‐regulated in human liver cancer; however, little is known about its regulatory function. Here, we establish HMGB2 as a new modulator of the pluripotency of mouse embryonic stem cells. Similar to octamer‐binding transcription factor 4 (OCT4) and sex‐determining region Y‐box 2 (SOX2), HMGB2 protein is highly expressed in undifferentiated CGR8 cells, whereas it undergoes rapid decline during embryonic body formation.